Skip to main content
  • Meeting abstract
  • Published:

Effects of stress-dose hydrocortisone therapy in septic shock (part II): soluble E-selectin and interleukin-6. Preliminary results of a double blinded, randomized, placebo-controlled cross-over study

Background

E-selectin is a member of the selectin family, i.e. a transmembrane molecule which is essential for the adherence and extravasation of leukocytes. E-selectin is expressed by activated endothelial cells and interacts with circulating neutrophiles. IL-6 is a proinflammatory cytokine, produced by various cell tvpes. Both markers are elevated in the blood of patients with septic shock; E-selectin possibly plays a role in permeability alterations and organ damage, IL-6 is a predictor of outcome and severity. Stress-dose hydrocortisone improves the clinical situation of patients in septic shock. In vivo studies could show that corticosteroids inhibit the endothelial expression of adhesion molecules including E-selectin.

Methods

As a part of a double blind controlled cross-over study with stress dose hydrocortisone (10 mg/h) E-selectin and IL-6 levels were monitored for six days in 20 patients with septic shock. For the first 3 days patients received either hydrocortisone or placebo as a continuous intravenous infusion, for the next 3 days medication was switched. Blood was taken before starting and then once every day. Both IL-6 and E-selectin were measured by an ELISA technique.

Results

We found a decrease in IL-6 and E-selectin levels under application of hydrocortisone compared to the placebo group as 2 well as to the primary values. After switching to placebo, values increased again.

Conclusion

We could show that stress-dose hydrocortisone given to patients in septic shock markedly decreases soluble E-selectin and IL-6 levels. In addition to the hemodynamic effects of this therapy, there also seems to be an immunmodulating and anti-inflammatory effect, which might be organ protective.

Figures 1-2.
figure 1

IL6 (Fig. 1) and E-selectin levels (Fig. 2) in septic shock patients, who received hydrocortisone therapy (see text). Day 0: before study. Data are presented as mean-values with SEM; n = 10 for each data point.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bercker, S., Ahlers, O., Keh, D. et al. Effects of stress-dose hydrocortisone therapy in septic shock (part II): soluble E-selectin and interleukin-6. Preliminary results of a double blinded, randomized, placebo-controlled cross-over study. Crit Care 3 (Suppl 1), P105 (2000). https://doi.org/10.1186/cc479

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc479

Keywords